Cargando…
Rapamycin Inhibits Cardiac Hypertrophy by Promoting Autophagy via the MEK/ERK/Beclin-1 Pathway
Rapamycin, also known as sirolimus, is an antifungal agent and immunosuppressant drug used to prevent organ rejection in transplantation. However, little is known about the role of rapamycin in cardiac hypertrophy and the signaling pathways involved. Here, the effect of rapamycin was examined using...
Autores principales: | Gu, Jun, Hu, Wei, Song, Zhi-Ping, Chen, Yue-Guang, Zhang, Da-Dong, Wang, Chang-Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796007/ https://www.ncbi.nlm.nih.gov/pubmed/27047390 http://dx.doi.org/10.3389/fphys.2016.00104 |
Ejemplares similares
-
Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2010) -
Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2009) -
Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer
por: Liu, Su, et al.
Publicado: (2020) -
Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway
por: Wang, Jun, et al.
Publicado: (2020) -
Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway
por: Yang, Jinjing, et al.
Publicado: (2018)